The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Tempest Therapeutics Inc(NASDAQ:TPST) 
Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated mechanisms with the potential to treat various tumors. The company is headquartered in South San Francisco, California.
Website: https://www.tempesttx.com/
Founded: 2011
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Share this website to your friends
Tempest Therapeutics Days Payable Outstanding ttm (DPO)
Tempest Therapeutics Op Cashflow Per Share ttm
Tempest Therapeutics Free Cashflow Per Share ttm
Tempest Therapeutics Cash Per Share ttm
Tempest Therapeutics (GAAP) P/E ratio ttm
Tempest Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.